Hyloris Pharmaceuticals Quote - 0AB6

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

Bid

Ask

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

28,000,000

Dividend Yield

PE Ratio

-9.83

Earnings Per Share (EPS)

-0.55

Revenue

4.21M

Net Profit

-15.38M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hyloris.com

Headquarters

Liege, Liege, Bel

Founded

Hyloris Pharmaceuticals Sa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0AB6. The last closing price for Hyloris Pharmaceuticals was -. Over the last year, Hyloris Pharmaceuticals shares have traded in a share price range of 0.00 € to 0.00 €.

Hyloris Pharmaceuticals currently has 28,000,000 shares outstanding. Hyloris Pharmaceuticals has a price to earnings ratio (PE ratio) of -9.83.

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Le total des produits et autres revenus atteint 4,4...

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Total revenue and other income amounted to...

Communication at the request of the FSMA on the transactions with Qliniq

Communication at the request of the FSMA on the transactions with Qliniq Communication at the request of the FSMA on the transactions with Qliniq Revision of 2022 and half-year of 2023 (HY 2023...

Communiqué à la requête de la FSMA sur les transactions avec QliniQ

Communiqué à la requête de la FSMA sur les transactions avec QliniQ Communiqué à la requête de la FSMA sur les transactions avec QliniQ Retraitement des états financiers de 2022 et de juin 2023...

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024 Liège, Belgique – le 8 mars 2024, 07:00 heures CET - Information non réglementée - Hyloris Pharmaceuticals SA (Euronext Bruxelles :...

Hyloris to Report 2023 Full-Year Results on 14 March 2024

Hyloris to Report 2023 Full-Year Results on 14 March 2024 Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a...

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada...

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Maxigesic® IV, a Potent Non-opioid...

Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures

Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures Innovative oral care solution aims to benefit...

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires Une...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

0AB6 - Frequently Asked Questions (FAQ)

What is the current Hyloris Pharmaceuticals share price?

The current share price of Hyloris Pharmaceuticals is 0.00 €

How many Hyloris Pharmaceuticals shares are in issue?

Hyloris Pharmaceuticals has 28,000,000 shares in issue

What is the 1 year trading range for Hyloris Pharmaceuticals share price?

Hyloris Pharmaceuticals has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Hyloris Pharmaceuticals?

The price to earnings ratio of Hyloris Pharmaceuticals is -9.83

What is the cash to sales ratio of Hyloris Pharmaceuticals?

The cash to sales ratio of Hyloris Pharmaceuticals is 35.88

What is the reporting currency for Hyloris Pharmaceuticals?

Hyloris Pharmaceuticals reports financial results in EUR

What is the latest annual turnover for Hyloris Pharmaceuticals?

The latest annual turnover of Hyloris Pharmaceuticals is EUR 4.21M

What is the latest annual profit for Hyloris Pharmaceuticals?

The latest annual profit of Hyloris Pharmaceuticals is EUR -15.38M

What is the registered address of Hyloris Pharmaceuticals?

The registered address for Hyloris Pharmaceuticals is BOULEVARD PATIENCE ET BEAUJONC, LIEGE, LIEGE, 4000

What is the Hyloris Pharmaceuticals website address?

The website address for Hyloris Pharmaceuticals is www.hyloris.com

Which industry sector does Hyloris Pharmaceuticals operate in?

Hyloris Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CHFChesterfield Resources Plc	0.40p (33.33%)	580.46k
DIADialight Plc	119.00p (29.70%)	514.97k
SAASMicrolise Group Plc	117.00p (27.17%)	783.4k
NFXNuformix Plc	0.145p (26.09%)	1.06B
BLOEBlock Energy Plc	0.80p (23.08%)	10.86M
SCGLSealand Capital Galaxy Limited	5.75p (-23.33%)	11.33M
CLAICel Ai Plc	0.27p (-21.74%)	31.9M
TYMTertiary Minerals Plc	0.0525p (-19.23%)	123.41M
DGIDg Innovate Plc	0.0175p (-18.60%)	144.64M
TRCThe Revel Collective Plc	0.225p (-18.18%)	2.03M
NFXNuformix Plc	0.145p (26.09%)	1.06B
VRSVersarien Plc	0.035p (1.45%)	994.63M
NTVONativo Resources Plc	0.0019p (-9.52%)	693.14M
UOGUnited Oil & Gas Plc	0.115p (17.95%)	360.68M
TRPTower Resources Plc	0.0295p (0.00%)	320.63M